PUBLISHER: The Business Research Company | PRODUCT CODE: 1945269
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945269
Heart closure devices are sophisticated medical instruments designed to close holes or openings in the heart, often resulting from congenital defects or surgical procedures. These devices are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart issues. Typically, they are delivered through catheter-based procedures, providing a safer alternative to open-heart surgery.
The main types of heart closure devices include atrial septal defect (ASD) closure devices, ventricular septal defect (VSD) closure devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure devices, and others. ASD closure devices are implants used to seal abnormal openings in the septum between the heart's upper chambers and are usually deployed through minimally invasive catheter-based procedures. These devices are commonly made from materials such as nitinol, stainless steel, and other substances. Delivery methods include both transcatheter and surgical approaches, and these devices are utilized in various healthcare settings such as hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratories.
Tariffs are impacting the heart closure devices market by increasing costs of imported nitinol materials, delivery catheters, imaging-compatible components, and precision manufacturing equipment. Cardiac hospitals and catheterization laboratories in North America and Europe are most affected due to reliance on imported high-performance devices, while Asia-Pacific faces higher production costs for export markets. These tariffs are elevating device prices and influencing procurement decisions. However, they are also supporting domestic device manufacturing, regional supply chain development, and innovation in cost-optimized minimally invasive cardiac solutions.
The heart closure devices market research report is one of a series of new reports from The Business Research Company that provides heart closure devices market statistics, including heart closure devices industry global market size, regional shares, competitors with a heart closure devices market share, detailed heart closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the heart closure devices industry. This heart closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The heart closure devices market size has grown rapidly in recent years. It will grow from $3.08 billion in 2025 to $3.46 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing prevalence of congenital heart defects, expansion of catheterization laboratories, growing adoption of minimally invasive cardiac treatments, rising awareness of structural heart conditions, availability of advanced imaging guidance.
The heart closure devices market size is expected to see rapid growth in the next few years. It will grow to $5.42 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing demand for catheter-based cardiac therapies, rising investments in structural heart disease treatment, expansion of specialized cardiac centers, growing focus on reducing surgical risks, technological advancements in closure device design. Major trends in the forecast period include increasing adoption of transcatheter heart closure procedures, rising demand for minimally invasive cardiac devices, growing use of nitinol-based closure systems, expansion of structural heart intervention programs, enhanced focus on procedural safety and efficacy.
The increasing incidence of cardiovascular diseases (CVDs) is expected to drive the growth of the heart closure devices market. The rise in CVDs is attributed to factors such as aging, unhealthy lifestyle choices, genetic predisposition, and a higher prevalence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices play a crucial role in minimizing complications caused by congenital heart defects by closing abnormal openings in the heart with minimal invasiveness, improving blood flow, and preventing further health issues. For instance, in May 2024, the Singapore Heart Foundation reported that cardiovascular diseases accounted for 26,885 deaths in 2023, with ischemic heart disease alone causing 5,302 deaths, showing a slight increase from the previous year. This growing incidence of cardiovascular diseases is driving the demand for heart closure devices market.
Major players in the heart closure devices market are prioritizing technological innovations, such as low-profile, ergonomic surgical LAA devices with continuous closing force mechanisms, to improve procedural precision, visibility, and ease of use for physicians while enhancing patient outcomes. Low-profile surgical LAA devices enable safe and effective closure of the left atrial appendage, offering optimal tissue compression, simplified single-handed placement, and improved access during minimally invasive procedures. For example, in August 2024, AtriCure, Inc., a US-based cardiac surgical solutions company, treated its first patient with the AtriClip FLEX-Mini device, the smallest-profile surgical LAA device available. Building on the established AtriClip platform, the device features a fully enclosed design with parallel beams that provide continuous closing force, enhanced visibility, and an ergonomic handle for single-handed placement, helping physicians deliver precise, safe, and efficient LAA management for patients with atrial fibrillation.
In November 2023, Johnson & Johnson MedTech, a US-based medical device company, acquired Laminar Inc. for $400 million. This acquisition enhances Johnson & Johnson MedTech's product offerings in cardiac arrhythmia treatment, strengthens its market presence in left atrial appendage elimination devices, and enables innovation in stroke prevention solutions for patients with non-valvular atrial fibrillation. Laminar Inc. is a US-based manufacturer specializing in heart closure devices.
Major companies operating in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., MicroPort Scientific Corporation
North America was the largest region in the heart closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the heart closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The heart closure devices market consists of sales of septal occluders, embolic protection devices, valvular closure devices, balloon occlusion devices, and transcatheter closure devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Heart Closure Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses heart closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for heart closure devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart closure devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.